CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea
NEW YORK, May 25, 2016 /PRNewswire/ -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea
Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.
In 2015, South Korea's population was approximately at 51.2 million. It has one of the world's highest population densities. The South Korean government has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the South Korean regulatory authorities recently made changes to the regulatory bodies overseeing the pharmaceutical and wider medical sectors, to provide a transparent, strong and efficient regulatory system to facilitate faster approval of pharmaceutical products and medical devices. The South Korean pharmaceutical market is one of the largest in Asia, estimated to be worth $18.2 billion in 2015 and expected to reach $20.4 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 2.4% over the 2008-2020 period. The medical device market was valued at $4.4 billion in 2008 and is expected to reach approximately $6.5 billion by 2020, at a projected CAGR of 6%. These positive trends can primarily be attributed to -
- An increasing elderly population in South Korea, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in South Korea, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Yuhan Corporation, Green Cross Corporation, Dong-A Pharmaceutical, Hanmi Pharmaceutical, and Daewoong Pharmaceuticals) and the medical device market (Siemens Healthcare, Johnson & Johnson, GE Healthcare, Baxter International, Philips Healthcare)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the South Korean healthcare market
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving South Korea's healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in South Korea's healthcare market
Read the full report: http://www.reportlinker.com/p02070138-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article